133 related articles for article (PubMed ID: 8597374)
1. Immunogenicity and stem cell content of class II depleted human vertebral body bone marrow.
Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
Ann N Y Acad Sci; 1995 Dec; 770():361-3. PubMed ID: 8597374
[No Abstract] [Full Text] [Related]
2. Induction of allogeneic unresponsiveness in adult dogs by irradiation and bone marrow transplantation: implication of Ia-positive bone marrow stem cells.
Rapaport FT; Bachvaroff RJ; Asari H; Sato K; Chanana AD; Joel DD; Cronkite EP
Ann N Y Acad Sci; 1985; 459():22-5. PubMed ID: 3913369
[No Abstract] [Full Text] [Related]
3. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow.
Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031
[No Abstract] [Full Text] [Related]
4. Canine pluripotent hematopoietic stem cells and CFU-GM express Ia-like antigens as recognized by two different class II-specific monoclonal antibodies.
Schuening F; Storb R; Goehle S; Meyer J; Graham T; Deeg HJ; Pesando J
Blood; 1987 Jan; 69(1):165-72. PubMed ID: 3539225
[TBL] [Abstract][Full Text] [Related]
5. Automated processing of human vertebral body bone marrow yields preparations with stem cell content similar to that obtained with traditional manual preparation.
Kenyon NS; Xu XM; Knapp J; Selvaggi GS; Bottino R; Kong SS; Qian T; Linetsky E; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3418. PubMed ID: 8540030
[No Abstract] [Full Text] [Related]
6. Selective expression of class-II MHC antigens during hemopoietic differentiation.
Katz FE; Davis L; Myers CD; Greaves MF
Exp Hematol; 1985 Dec; 13(11):1182-7. PubMed ID: 3864642
[TBL] [Abstract][Full Text] [Related]
7. Suitability of neonatal vertebral body marrow for transplant applications.
Kong SS; Selvaggi G; Kenyon N; Knapp J; Olson L; Tzakis AG; Miller J; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3416. PubMed ID: 8540028
[No Abstract] [Full Text] [Related]
8. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M
Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439
[No Abstract] [Full Text] [Related]
9. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow.
Hardwick A; Law P; Mansour V; Kulcinski D; Ishizawa L; Gee A
Prog Clin Biol Res; 1992; 377():583-9. PubMed ID: 1279728
[No Abstract] [Full Text] [Related]
10. Antigenic characteristics of normal and malignant human hematopoietic cells. Potential use of antigenic differences in cell separation and marrow transplantation.
Cline MJ; Fitchen JH; Foon K; Billing R
Exp Hematol; 1979; 7 Suppl 5():246-51. PubMed ID: 400688
[TBL] [Abstract][Full Text] [Related]
11. CD34 positive cell selection by immunomagnetic techniques.
Bigas A; Amill B; Canals C; Tugues D; García J
Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
[No Abstract] [Full Text] [Related]
12. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.
Inaba K; Inaba M; Deguchi M; Hagi K; Yasumizu R; Ikehara S; Muramatsu S; Steinman RM
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3038-42. PubMed ID: 8464920
[TBL] [Abstract][Full Text] [Related]
13. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice.
Markowitz JS; Auchincloss H; Grusby MJ; Glimcher LH
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2779-83. PubMed ID: 8464889
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived cells fail to induce positive selection in thymus reaggregation cultures.
Ernst BB; Surh CD; Sprent J
J Exp Med; 1996 Mar; 183(3):1235-40. PubMed ID: 8642265
[TBL] [Abstract][Full Text] [Related]
15. Dichotomy in the tissue origin of schistosome acquired class I and class II major histocompatibility complex antigens.
Sher A; Sacks DL; Simpson AJ; Singer A
J Exp Med; 1984 Mar; 159(3):952-7. PubMed ID: 6366108
[TBL] [Abstract][Full Text] [Related]
16. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
De Fazio SR; Kowolenko M; Monaco AP; Gozzo JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):547-8. PubMed ID: 2856297
[No Abstract] [Full Text] [Related]
17. Measurement of marrow repopulating potential of human hematopoietic progenitor and stem cells using a fetal sheep model.
Traycoff CM; Hoffman R; Zanjani ED; Cornetta K; Law P; Gianni AM; Bregni M; Siena S; Abboud MR; Laver J
Prog Clin Biol Res; 1994; 389():281-91. PubMed ID: 7535433
[No Abstract] [Full Text] [Related]
18. Ex vivo expansion of CD34+ hematopoietic progenitors.
Moore MA; Schneider JG; Shapiro F; Bengala C
Prog Clin Biol Res; 1994; 389():217-28. PubMed ID: 7535432
[No Abstract] [Full Text] [Related]
19. Hematopoietic stem cell chimerism: relationships between degree of chimerism, T cell clonal deletion, and graft survival.
Taniguchi H; Jinzenji Y; Fukao K; Nakauchi H
Transplant Proc; 1994 Aug; 26(4):1966-8. PubMed ID: 8066636
[No Abstract] [Full Text] [Related]
20. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
